0001144204-15-027522.txt : 20150505 0001144204-15-027522.hdr.sgml : 20150505 20150505130846 ACCESSION NUMBER: 0001144204-15-027522 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150429 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20150505 DATE AS OF CHANGE: 20150505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PSYCHEMEDICS CORP CENTRAL INDEX KEY: 0000806517 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 581701987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13738 FILM NUMBER: 15831684 BUSINESS ADDRESS: STREET 1: 125 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-206-8220 MAIL ADDRESS: STREET 1: 125 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 v409387_8-k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

Current Report

Pursuant To Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) April 29, 2015

 

PSYCHEMEDICS CORPORATION

(Exact Name of Registrant As Specified In Its Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

1-13738 58-1701987
(Commission File Number) (I.R.S. Employer Identification No.)
   
125 Nagog Park, Acton, Massachusetts 01720
(Address of Principal Executive Offices) (Zip Code)
   

 

(978) 206-8220

(Registrant’s Telephone Number, Including Area Code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

ITEM 5.07SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

At the 2015 Annual Meeting, the following items were voted on by stockholders:

 

a. Messrs. Raymond C Kubacki, Harry Connick, Walter S. Tomenson, Jr. and Fred J. Weinert were each elected by the stockholders to a term to expire in 2016.  

 

Nominees

  For   Withheld   Broker
Non-Votes		 
Raymond C. Kubacki   3,369,168    6,287    1,567,086 
Harry Connick   3,341,135    34,320    1,567,086 
Walter S. Tomenson, Jr.   3,363,489    11,966    1,567,086 
Fred J. Weinert   3,361,362    14,093    1,567,086 

 

b. The stockholders approved, on an advisory (non-binding) basis, the compensation paid to the Corporation’s named executive officers disclosed in the Proxy Statement, including the compensation tables and related disclosure.

 

For   Against   Abstain   Broker
Non-Votes
3,027,281   323,389   24,785   1,567,086

 

c. Management’s proposal to ratify the appointment of BDO USA, LLP as Psychemedics’ independent registered public accounting firm for 2015 was approved.

 

         
For   Against   Abstain
4,924,540   11,494   6,507

 

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PSYCHEMEDICS CORPORATION
Dated: May 5, 2015    
     
     
  By: /s/ Neil L. Lerner  
    Neil L. Lerner,
    Vice President – Finance